Showing results (1401-1410 of 1,757) with videos related to
Sort By:
Pageof 176
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|March 30, 2012
[A modified Calgary syncope syndrome score in the differential diagnosis between cardiac syncope and vasovagal syncope]Hong-fang Jin, Jin-yan Yang, Xue-ying Li, et al.Journal of Ethnopharmacology|April 23, 2023
Anthraquinone metabolites isolated from the rhizosphere soil Streptomyces of Panax notoginseng (Burk.) F. H. Chen target MMP2 to inhibit cancer cell migrationJin-Yan Xue, Ying-Ying Wu, Yu-Ling Han, et al.Leukemia & Lymphoma|July 25, 2020
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphomaTong Lu, Leonid Gibiansky, Xiaobin Li, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2019
Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcomaJin-Yan Wang, Yan Yang, Yajun Ma, et al.The Review of Scientific Instruments|February 20, 2026
An automated system for electrodeposition of polymer thin films and their wetting analysisHarley Quinn, Gregory A Robben, Zhaoyi Zheng, et al.Journal of Virology|January 31, 2020
Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High OncogenicitySiaw Shi Boon, Chichao Xia, Jin Yan Lim, et al.Phytochemistry|March 8, 2008
Stereumin A-E, sesquiterpenoids from the fungus Stereum sp. CCTCC AF 207024Guo-Hong Li, Meng Duan, Ze-Fen Yu, et al.Dong Wu Xue Yan Jiu = Zoological Research|May 29, 2015
Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdownLin Zhang, Xu-He Huang, Ping-Ping Zhou, et al.Journal of Cellular and Molecular Medicine|June 30, 2018
Lipopolysaccharide enhances ADAR2 which drives Hirschsprung's disease by impairing miR-142-3p biogenesisLei Peng, Hua Zhang, Yang Su, et al.Pulmonary Pharmacology & Therapeutics|August 28, 2017
Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthmaRui Zhu, Yanan Zheng, Nathanael L Dirks, et al.Pageof 176